Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
New Treatment Strategy Offers Hope To Rheumatoid Arthritis Patients Who Failed All Other Therapies
ScienceDaily, 06/19/09
Rheumatoid arthritis (RA) patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months, according to the results of a new study.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
New computer model could lead to safer stents
ScienceDaily, 12/03/09
Half of worlds ICU patients have infections
Reuters, 12/03/09
Beverage Can Tabs Still Dangerous
Ivanhoe, 12/02/09